112 related articles for article (PubMed ID: 15831599)
21. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
22. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
23. The use of drug eluting stents in single and multivessel disease: results from a single centre experience.
Mikhail GW; Airoldi F; Tavano D; Chieffo A; Rogacka R; Carlino M; Montorfano M; Sangiorgi G; Corvaja N; Michev I; Orlic D; Di Mario C; Colombo A
Heart; 2004 Sep; 90(9):990-4. PubMed ID: 15310680
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.
Schafer PE; Sacrinty MT; Cohen DJ; Kutcher MA; Gandhi SK; Santos RM; Little WC; Applegate RJ
Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):408-15. PubMed ID: 21693724
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
Williams DO; Abbott JD; Kip KE;
Circulation; 2006 Nov; 114(20):2154-62. PubMed ID: 17060386
[TBL] [Abstract][Full Text] [Related]
27. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
28. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Chu WW; Kuchulakanti PK; Torguson R; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592
[TBL] [Abstract][Full Text] [Related]
29. Are drug eluting stents really worth the money?
Thomas M
Heart; 2006 Jan; 92(1):5-7. PubMed ID: 15939723
[TBL] [Abstract][Full Text] [Related]
30. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
[TBL] [Abstract][Full Text] [Related]
32. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
[TBL] [Abstract][Full Text] [Related]
33. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
Tomai F; Reimers B; De Luca L; Galassi AR; Gaspardone A; Ghini AS; Ferrero V; Favero L; Gioffrè G; Prati F; Tamburino C; Ribichini F
Diabetes Care; 2008 Jan; 31(1):15-9. PubMed ID: 17909090
[TBL] [Abstract][Full Text] [Related]
34. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and Paclitaxel-eluting polymer-based stents, and bare metal stents].
de la Torre Hernández JM; Sainz Laso F; Ruisánchez C; Zueco J; Figueroa A; Colman T
Rev Esp Cardiol; 2005 Mar; 58(3):262-9. PubMed ID: 15766448
[TBL] [Abstract][Full Text] [Related]
36. A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents.
Hannan EL; Racz M; Holmes DR; Sharma S; Katz S; Walford G; King SB; Clark LT; Jones RH
Am Heart J; 2007 Sep; 154(3):545-53. PubMed ID: 17719304
[TBL] [Abstract][Full Text] [Related]
37. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
38. [Antiproliferative drug-eluting stents: systematic review of the benefits and estimate of economic impact].
Oliva G; Espallargues M; Pons JM
Rev Esp Cardiol; 2004 Jul; 57(7):617-28. PubMed ID: 15274846
[TBL] [Abstract][Full Text] [Related]
39. Drug-eluting stents: new era and new concerns.
Bhatia V; Bhatia R; Dhindsa M
Postgrad Med J; 2004 Jan; 80(939):13-8. PubMed ID: 14760171
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease.
Griffiths H; Bakhai A; West D; Petrou M; De Souza T; Moat N; Pepper J; Di Mario C
Eur J Cardiothorac Surg; 2004 Sep; 26(3):528-34. PubMed ID: 15302047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
